RETNLB and Alzheimer disease: AD-MSC-sEVs significantly decreased the expression of pro-inflammatory (Tnf-a and Inos) macrophage factors and increased the expression of both pro-inflammatory (Mcp-1) and anti-inflammatory (Il-10, Fizz-1, Cd206) macrophage factors.